Virtify Elevates John P. Murgo to Chief Operating Officer

Virtify Elevates John P. Murgo to Chief Operating Officer
Murgo Adds COO Responsibilities to his Role as CFO to Manage Increasing Levels of Growth and Operational Activity

Cambridge, Mass. - July 19, 2010 - Virtify, Inc. today announced that it has promoted John P. Murgo to the role of chief operating officer (COO), in addition to his existing responsibilities as executive vice president/chief financial officer (CFO) for the company. In his expanded role, Murgo will be managing the integration of people and processes within sales, marketing, product implementation and customer support - to enable successful alignment of product delivery and support with growing customer demand.

"The compliance and process improvement challenges that are facing life sciences companies have presented tremendous market opportunities for Virtify, and our products help customers manage the complexity of these challenges in a cost-effective and efficient manner," said Satish Tadikonda, president and CEO of Virtify. "Given these dynamic market conditions, we are very confident that John's expertise in leading teams and operations will help take us to our next level of success."

Murgo has more than 15 years of experience as a successful senior executive in the software industry. Most recently, he served as executive vice president/CFO of Acronis, a provider of scalable storage management and disaster recovery software, where he contributed to Acronis' growth from approximately $20M to $120M in revenue in two and a half years. Prior to Acronis, Murgo was EVP/CFO of OpenService (now known as LogMatrix), a provider of compliance, security and network management solutions. Murgo has also held a variety of executive management roles including CFO of Dirig Software, CEO of Process Software and CFO/COO of HPSC, a publicly-traded company on NASDAQ. Murgo is an alumnus of Price Waterhouse Coopers, a graduate of Bentley University and also a CPA. He currently serves on the board of directors of IMN and Tauntr.

"Virtify is in the midst of an exciting period of growth and expansion, including the recent release of our new clinical trial disclosure software product CTRR Enterprise 2.0, and several new products on the near-term horizon," said Murgo. I look forward to leading Virtify's operations as we develop new solutions to help life sciences companies achieve and sustain compliance, enhance productivity and accelerate time-to-market of their products.

About Virtify
Virtify is the market leader in Enterprise Content Compliance (ECC) software solutions for life sciences. Organizations rely on Virtify solutions to accelerate time-to-market, mitigate risk, and reduce costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use ECC software suite is the industry's only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire continuum - from pre-clinical through product registration to commercialization. The company plays a leadership role in the development of global regulatory standards and is an active participant in a variety of standards committees. Virtify's software products combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's leading life sciences companies. Located on the Web at www.virtify.com

Suggested Articles

The duo will carry out a phase 2 study of BioNTech’s mRNA cancer immunotherapy in combination with Sanofi and Regeneron’s PD-1 blocker, Libtayo.

Merck was purposely cautious during the start of the pandemic when it came to vaccine development but is now slowly but surely ramping up its efforts

The money will equip AlloVir to embark on a broad clinical development program for a phase 3-ready cell therapy that targets five viruses.